Hirsch Stanley 4
4 · Foamix Pharmaceuticals Ltd. · Filed Mar 3, 2020
Insider Transaction Report
Form 4
Hirsch Stanley
Director
Transactions
- Award
Ordinary Shares
2020-02-27+42,493→ 111,858 total
Holdings
- 182,500(indirect: See footnote)
Ordinary Shares
Footnotes (3)
- [F1]This security represents restricted share units. Each restricted share unit represents a contingent right to receive one ordinary share of the issuer.
- [F2]The ordinary shares underlying this restricted share unit award vest over a 12 month period, in equal, quarterly installments, ending February 27, 2021.
- [F3]Securities are held by ZEAS Technology and Science Management Ltd., a company beneficially owned by Stanley Hirsch.